IIUM Repository

Interrogating novel compounds for improved anti-dengue therapies via inhibition of human hexokinase II (HKII)

Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea (2020) Interrogating novel compounds for improved anti-dengue therapies via inhibition of human hexokinase II (HKII). In: Nanotechnology Symposium 2020, 21st Feb. 2020, Kuala Lumpur, Malaysia. (Unpublished)

[img]
Preview
PDF - Published Version
Download (864kB) | Preview

Abstract

Dengue is one of the most fatal infectious diseases in the world, which is caused by dengue virus (DENV). Regrettably until now, specific treatment for the disease has not been established. It has been reported that a human glycolytic enzyme, the human hexokinase II (HKII) has a great impact in supporting viral replication in the host cell, thus the enzyme has been proposed as an anti-DENV drug target. The main aim of this research is to identify novel anti-DENV agents for the treatment of dengue disease through in silico screening and HKII enzymatic inhibition studies.

Item Type: Conference or Workshop Item (Poster)
Additional Information: 7200/87224
Uncontrolled Keywords: Dengue virus, dengue therapies, human kexokinase II, anti-dangue
Subjects: Q Science > Q Science (General)
Q Science > QD Chemistry
R Medicine > RM Therapeutics. Pharmacology
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button): Kulliyyah of Engineering > Department of Biotechnology Engineering
Kulliyyah of Engineering
Depositing User: Dr Fazia Adyani Ahmad Fuad
Date Deposited: 30 Dec 2020 09:59
Last Modified: 30 Dec 2020 09:59
URI: http://irep.iium.edu.my/id/eprint/87224

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year